NEW YORK (GenomeWeb News) – Labcyte and Allegro Technologies, which conducts business as Deerac Fluidics, have agreed to merge, the companies said Sunday.
Financial terms of the deal were not disclosed.
Labcyte offers a droplet ejection technology that is used in compound management, assays, arraying, particle manufacturing, imaging mass spectrometry, and live cell transfer.
Deerac, based in Dublin, Ireland, specializes in genomic assay technologies and makes liquid handling technologies that can dispense nanoliter and microliter volumes. The companies said their technologies “can be used together, when one component of an assay is added in the low nanoliter range and others are added in larger amounts.”
Combining their product lines will allow the firms to develop their technologies for a wider range of applications, they said.